Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Quantify Chronic Kidney Disease Clinical Outcomes Database

The current version of the database includes clinical safety and efficacy information on treatment options currently approved or in development for Chronic Kidney Disease (CKD) progression
in patients with Type 2 Diabetes Mellitus (T2DM) and overt albuminuria/proteinuria, as well as patients with IGA nephropathy.

Solution: PK/PD Modeling & Simulation
More Info

Quantify CD Clinical Outcomes Database

The current version of the database contains information from randomized controlled trails on all current biologic and small molecule drugs that are evaluated for moderate-to-severe Crohn’s disease in patients that failed conventional treatment.

Solution: PK/PD Modeling & Simulation
More Info

Quantify AS Clinical Outcomes Database

The Quantify AS Clinical Outcomes Database is developed to document clinical safety and efficacy information from randomized controlled trials investigating biologics currently approved or in development for ankylosing spondylitis (AS).

Solution: PK/PD Modeling & Simulation
More Info

Quantify ALL Clinical Outcomes Database

The Quantify Acute Lymphoblastic Leukemia (ALL) Clinical Outcomes Database documents clinical efficacy information in infants, children, and adults following salvage treatment for relapsed/refractory patients.

Solution: PK/PD Modeling & Simulation
Therapeutic Area: Oncology/Hematology
More Info

Quantify AD Clinical Outcomes Database

The current version of the database includes clinical safety and efficacy information on all symptomatic drugs as well as newer Abeta drugs currently approved or in development for Alzheimer Disease (AD).

Solution: PK/PD Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info

Quantify Depression Clinical Outcomes Database

The Quantify Major Depression Disorder (MDD) Clinical Outcomes Database documents clinical efficacy and safety information from randomized and controlled regulatory trials investigating monotherapy and adjunctive therapy pharmaceutical drugs for major depression disorder and treatment-resistant depression.

Solution: PK/PD Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info
Learn More LinkedIn Twitter Facebook Email